nib Group concludes sale of nib Travel

nib Group (ASX: NHF) today confirmed completion of both previously announced sale transactions of nib Travel, representing the final major milestone in the sale of its travel insurance businesses.

nib Group completed the sale of its Australian and New Zealand travel insurance businesses to Allianz Partners, effective 17 September 2026, and also completed the sale of its World Nomads international travel insurance business to International Medical Group (IMG), a wholly-owned subsidiary of SiriusPoint, effective 30 September 2026.

Cash consideration received on completion was $97.6 million, as outlined in our FY2026 Full Year Results Presentation, with up to $10 million eligible deferred consideration in FY28.

nib Managing Director and Chief Executive Officer, Ed Close, said the transactions support nib’s strategy to simplify its portfolio and focus on its core health insurance and health-related businesses.

The completion of these transactions marks an important milestone for nib

The completion of these transactions marks an important milestone for nib, further strengthening our focus on our core health insurance and health-related businesses. We are pleased to have transferred these travel insurance businesses to partners with deep industry expertise, global scale and strong growth ambitions,” Mr Close said.

nib will continue to distribute nib-branded travel insurance in Australia and New Zealand under a long-term strategic partnership with Allianz Partners. Transitional services and support arrangements will continue for both transactions for a period to support continuity for customers and partners.

nib indicated its planned use of the nib Travel sale proceeds in its FY2026 Full Year Results Presentation, which included a special dividend of 5.0 cps in its FY26 final dividend to be paid to shareholders on 7 October 2026 with further capital management optionality available.

This announcement has been authorised for release by Jordan French, nib Company Secretary.